These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 30230627)

  • 21. A53T-α-synuclein overexpression in murine locus coeruleus induces Parkinson's disease-like pathology in neurons and glia.
    Henrich MT; Geibl FF; Lee B; Chiu WH; Koprich JB; Brotchie JM; Timmermann L; Decher N; Matschke LA; Oertel WH
    Acta Neuropathol Commun; 2018 May; 6(1):39. PubMed ID: 29747690
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunochemical Detection of α-Synuclein Autoantibodies in Parkinson's Disease: Correlation between Plasma and Cerebrospinal Fluid Levels.
    Horvath I; Iashchishyn IA; Forsgren L; Morozova-Roche LA
    ACS Chem Neurosci; 2017 Jun; 8(6):1170-1176. PubMed ID: 28263550
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ELISA method to detect α-synuclein oligomers in cell and animal models.
    Lassen LB; Gregersen E; Isager AK; Betzer C; Kofoed RH; Jensen PH
    PLoS One; 2018; 13(4):e0196056. PubMed ID: 29698510
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of Prodromal Parkinson's Disease as Defined by MDS Research Criteria among Elderly Patients Undergoing Colonoscopy.
    Skorvanek M; Ladomirjakova Z; Han V; Lesko N; Feketeova E; Jarcuskova D; Repkova B; Spisak P; Urbancikova Z; Vargova A; Gombosova L; Zakuciova M; Veseliny E; Trebuna F; Mechirova E; Gdovinova Z
    J Parkinsons Dis; 2017; 7(3):481-489. PubMed ID: 28387681
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathological interface between oligomeric alpha-synuclein and tau in synucleinopathies.
    Sengupta U; Guerrero-Muñoz MJ; Castillo-Carranza DL; Lasagna-Reeves CA; Gerson JE; Paulucci-Holthauzen AA; Krishnamurthy S; Farhed M; Jackson GR; Kayed R
    Biol Psychiatry; 2015 Nov; 78(10):672-83. PubMed ID: 25676491
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vivo markers of Parkinson's disease and dementia with Lewy bodies: current value of the 5G4 α-synuclein antibody.
    Maetzler W; Pilotto A; Apel A; Deuschle C; Kuebart G; Heinzel S; Liepelt-Scarfone I; Schulte C; Reusch D; Schleicher E; Rothfuss O; Schneider A; Dodel R; Gasser T; Berg D
    Acta Neuropathol; 2014 Dec; 128(6):893-5. PubMed ID: 25376537
    [No Abstract]   [Full Text] [Related]  

  • 27. Parkinson disease: Peripheral α-synuclein deposits - prodromal markers for Parkinson disease?
    Wood H
    Nat Rev Neurol; 2016 May; 12(5):249. PubMed ID: 27080519
    [No Abstract]   [Full Text] [Related]  

  • 28. Author response.
    Visanji NP; Lang AE; Hazrai LN
    Neurology; 2015 Sep; 85(9):834-5. PubMed ID: 26554095
    [No Abstract]   [Full Text] [Related]  

  • 29. Novel conformation-selective alpha-synuclein antibodies raised against different in vitro fibril forms show distinct patterns of Lewy pathology in Parkinson's disease.
    Covell DJ; Robinson JL; Akhtar RS; Grossman M; Weintraub D; Bucklin HM; Pitkin RM; Riddle D; Yousef A; Trojanowski JQ; Lee VM
    Neuropathol Appl Neurobiol; 2017 Dec; 43(7):604-620. PubMed ID: 28386933
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Colonic bacterial composition in Parkinson's disease.
    Keshavarzian A; Green SJ; Engen PA; Voigt RM; Naqib A; Forsyth CB; Mutlu E; Shannon KM
    Mov Disord; 2015 Sep; 30(10):1351-60. PubMed ID: 26179554
    [TBL] [Abstract][Full Text] [Related]  

  • 31. α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study.
    Mollenhauer B; Locascio JJ; Schulz-Schaeffer W; Sixel-Döring F; Trenkwalder C; Schlossmacher MG
    Lancet Neurol; 2011 Mar; 10(3):230-40. PubMed ID: 21317042
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Systemic Synuclein Sampling Study: toward a biomarker for Parkinson's disease.
    Visanji NP; Mollenhauer B; Beach TG; Adler CH; Coffey CS; Kopil CM; Dave KD; Foroud T; Chahine L; Jennings D;
    Biomark Med; 2017 Apr; 11(4):359-368. PubMed ID: 28353371
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Accumulation of α-synuclein in the bowel of patients in the pre-clinical phase of Parkinson's disease.
    Hilton D; Stephens M; Kirk L; Edwards P; Potter R; Zajicek J; Broughton E; Hagan H; Carroll C
    Acta Neuropathol; 2014 Feb; 127(2):235-41. PubMed ID: 24240814
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterisation of isolated alpha-synuclein filaments from substantia nigra of Parkinson's disease brain.
    Crowther RA; Daniel SE; Goedert M
    Neurosci Lett; 2000 Oct; 292(2):128-30. PubMed ID: 10998565
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunotherapy targeting α-synuclein, with relevance for future treatment of Parkinson's disease and other Lewy body disorders.
    Lindström V; Ihse E; Fagerqvist T; Bergström J; Nordström E; Möller C; Lannfelt L; Ingelsson M
    Immunotherapy; 2014; 6(2):141-53. PubMed ID: 24491088
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation.
    Tong J; Wong H; Guttman M; Ang LC; Forno LS; Shimadzu M; Rajput AH; Muenter MD; Kish SJ; Hornykiewicz O; Furukawa Y
    Brain; 2010 Jan; 133(Pt 1):172-88. PubMed ID: 19903734
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Schizophrenia as a prodromal symptom in a patient harboring SNCA duplication.
    Takamura S; Ikeda A; Nishioka K; Furuya H; Tashiro M; Matsushima T; Li Y; Yoshino H; Funayama M; Morinobu S; Hattori N
    Parkinsonism Relat Disord; 2016 Apr; 25():108-9. PubMed ID: 26880146
    [TBL] [Abstract][Full Text] [Related]  

  • 38. First-in-human assessment of PRX002, an anti-α-synuclein monoclonal antibody, in healthy volunteers.
    Schenk DB; Koller M; Ness DK; Griffith SG; Grundman M; Zago W; Soto J; Atiee G; Ostrowitzki S; Kinney GG
    Mov Disord; 2017 Feb; 32(2):211-218. PubMed ID: 27886407
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mitochondrial dynamics in Parkinson's disease: a role for α-synuclein?
    Pozo Devoto VM; Falzone TL
    Dis Model Mech; 2017 Sep; 10(9):1075-1087. PubMed ID: 28883016
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sticking it to Parkinson's disease.
    Leslie M
    Sci Aging Knowledge Environ; 2005 Jun; 2005(25):nf46. PubMed ID: 15975896
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.